Ligand Pharmaceuticals, Inc. (LGND)
183.09
-0.94
(-0.51%)
USD |
NASDAQ |
Dec 11, 16:00
183.09
0.00 (0.00%)
After-Hours: 16:40
Ligand Pharmaceuticals EPS Diluted (Quarterly): 5.685 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 2.316 |
| Inspire Medical Systems, Inc. | 0.3355 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Johnson & Johnson | 2.121 |
| AbbVie, Inc. | 0.0993 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 117.27M |
| Revenue (Quarterly) | 115.46M |
| Total Expenses (Quarterly) | -1.812M |
| Enterprise Value | 3.408B |
| Gross Profit Margin (Quarterly) | 89.70% |
| Earnings Yield | 1.13% |
| Operating Earnings Yield | 0.80% |
| Normalized Earnings Yield | 0.1232 |